OMER
Price
$4.29
Change
-$0.01 (-0.23%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
292.64M
43 days until earnings call
TGTX
Price
$35.57
Change
+$0.60 (+1.72%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
5.64B
37 days until earnings call
Interact to see
Advertisement

OMER vs TGTX

Header iconOMER vs TGTX Comparison
Open Charts OMER vs TGTXBanner chart's image
Omeros
Price$4.29
Change-$0.01 (-0.23%)
Volume$6.25K
Capitalization292.64M
TG Therapeutics
Price$35.57
Change+$0.60 (+1.72%)
Volume$66.28K
Capitalization5.64B
OMER vs TGTX Comparison Chart in %
Loading...
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMER vs. TGTX commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMER is a Buy and TGTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (OMER: $4.28 vs. TGTX: $35.57)
Brand notoriety: OMER and TGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OMER: 119% vs. TGTX: 98%
Market capitalization -- OMER: $291.28M vs. TGTX: $5.64B
OMER [@Biotechnology] is valued at $291.28M. TGTX’s [@Biotechnology] market capitalization is $5.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMER’s FA Score shows that 1 FA rating(s) are green whileTGTX’s FA Score has 1 green FA rating(s).

  • OMER’s FA Score: 1 green, 4 red.
  • TGTX’s FA Score: 1 green, 4 red.
According to our system of comparison, TGTX is a better buy in the long-term than OMER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMER’s TA Score shows that 3 TA indicator(s) are bullish while TGTX’s TA Score has 6 bullish TA indicator(s).

  • OMER’s TA Score: 3 bullish, 4 bearish.
  • TGTX’s TA Score: 6 bullish, 5 bearish.
According to our system of comparison, TGTX is a better buy in the short-term than OMER.

Price Growth

OMER (@Biotechnology) experienced а +6.20% price change this week, while TGTX (@Biotechnology) price change was +11.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

OMER is expected to report earnings on Nov 05, 2025.

TGTX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TGTX($5.64B) has a higher market cap than OMER($293M). TGTX YTD gains are higher at: 16.179 vs. OMER (-56.478). TGTX has higher annual earnings (EBITDA): 97.6M vs. OMER (-125.18M). TGTX has more cash in the bank: 252M vs. OMER (28.7M). OMER has less debt than TGTX: OMER (184M) vs TGTX (254M). TGTX has higher revenues than OMER: TGTX (454M) vs OMER (0).
OMERTGTXOMER / TGTX
Capitalization293M5.64B5%
EBITDA-125.18M97.6M-128%
Gain YTD-56.47816.179-349%
P/E RatioN/A93.61-
Revenue0454M-
Total Cash28.7M252M11%
Total Debt184M254M72%
FUNDAMENTALS RATINGS
OMER vs TGTX: Fundamental Ratings
OMER
TGTX
OUTLOOK RATING
1..100
6923
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
85
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
1136
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OMER's Valuation (37) in the Biotechnology industry is somewhat better than the same rating for TGTX (85). This means that OMER’s stock grew somewhat faster than TGTX’s over the last 12 months.

TGTX's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as OMER (100). This means that TGTX’s stock grew similarly to OMER’s over the last 12 months.

OMER's SMR Rating (11) in the Biotechnology industry is in the same range as TGTX (36). This means that OMER’s stock grew similarly to TGTX’s over the last 12 months.

TGTX's Price Growth Rating (55) in the Biotechnology industry is in the same range as OMER (60). This means that TGTX’s stock grew similarly to OMER’s over the last 12 months.

TGTX's P/E Growth Rating (6) in the Biotechnology industry is significantly better than the same rating for OMER (100). This means that TGTX’s stock grew significantly faster than OMER’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMERTGTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
OMER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GUROF3.100.08
+2.65%
Guru Organic Energy Co.
ADVOF24.19N/A
N/A
ADVA AG Optical Networking
OCLDY13.34N/A
N/A
Orica Ltd.
RBGPF76.60N/A
N/A
Reckitt Benckiser Group Plc.
MNXXF0.04N/A
-5.27%
Manganese X Energy Corp.

OMER and

Correlation & Price change

A.I.dvisor indicates that over the last year, OMER has been loosely correlated with INM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMER
1D Price
Change %
OMER100%
+2.87%
INM - OMER
46%
Loosely correlated
-0.87%
TGTX - OMER
32%
Poorly correlated
+8.03%
FULC - OMER
32%
Poorly correlated
+0.81%
ACIU - OMER
32%
Poorly correlated
+3.27%
MDXG - OMER
31%
Poorly correlated
+2.42%
More

TGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TGTX has been loosely correlated with KRYS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TGTX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TGTX
1D Price
Change %
TGTX100%
+8.03%
KRYS - TGTX
39%
Loosely correlated
+1.13%
CLLS - TGTX
36%
Loosely correlated
+6.69%
ACLX - TGTX
34%
Loosely correlated
+0.46%
OMER - TGTX
33%
Loosely correlated
+2.87%
ROIV - TGTX
32%
Poorly correlated
-0.66%
More